Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q2 2025 Earnings

May 14Confirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.67

-0.15

0.36

0.88

Details

Expected EPS

-0.1

Actual EPS

-0.15

Surprise EPS

-0.05

Surprise Percent

-50%

Description

⁨Inhibikase Therapeutics⁩ (⁦IKT⁩) has reported earnings of ⁦-0.15⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.